您的位置: 首页 > 农业专利 > 详情页

GPC3-TARGETING THERAPEUTIC AGENT WHICH IS ADMINISTERED TO PATIENT FOR WHOM THE GPC3-TARGETING THERAPEUTIC AGENT IS EFFECTIVE
专利权人:
CHUGAI SEIYAKU KABUSHIKI KAISHA
发明人:
Toshihiko OHTOMO,Takayoshi TANAKA,Yasuo SUGITANI
申请号:
US15741219
公开号:
US20180169237A1
申请日:
2016.06.30
申请国别(地区):
US
年份:
2018
代理人:
摘要:
The present invention provides a method for determining the efficacy of a GPC3-targeting therapeutic agent for a liver cancer patient and a GPC3-targeting therapeutic agent or a preparation which is to be administered to a patient for whom it has been determined that the GPC3-targeting therapeutic agent is effective. The present invention provides, for example, a method for determining that a GPC3-targeting therapeutic agent is effective when the expression level of GPC3 per tumor cell is a predetermined value, and a GPC3-targeting therapeutic agent or a preparation which is to be administered to a patient for whom it has been determined that the GPC3-targeting therapeutic agent is effective.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/
相关发明人
相关专利

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充